- Advanced search
|International Nonproprietary Names|
|Search PubMed clinical trials||rilotumumab|
|Search PubMed titles||rilotumumab|
|Search PubMed titles/abstracts||rilotumumab|
|Rilotumumab is a monoclonal antibody directed against hepatocyte growth factor (HGF), developed as a treatment for solid tumours.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. Peptide sequence BLAST search using the heavy and light chain variable regions of rilotumumab provides 100% matches to sequences covered by patent US8609090 , and to the antibody with designation 2.12.1.